Modified Glasgow Prognostic Score at Recurrence Predicts Poor Survival in Resected Non-Small Cell Lung Cancer (NSCLC) Patients.
CONCLUSIONS mGPS at the time of recurrence might be an independent adverse prognostic factor in recurrent NSCLC.
PMID: 28775246 [PubMed - in process]
Source: Medical Science Monitor - Category: Research Tags: Med Sci Monit Source Type: research
More News: Biomedical Science | Cancer | Cancer & Oncology | Lung Cancer | Non-Small Cell Lung Cancer | Research | Science | Statistics | Study